{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:13:08Z","timestamp":1795111988158,"version":"4.10.3"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Macrophages are abundant immune cells in the microenvironment of diffuse large B-cell lymphoma (DLBCL). Macrophage estimation by immunohistochemistry shows varying prognostic significance across studies in DLBCL, and does not provide a comprehensive analysis of macrophage subtypes. Here, using digital spatial profiling with whole transcriptome analysis of CD68+ cells, we characterize macrophages in distinct spatial niches of reactive lymphoid tissues (RLTs) and DLBCL. We reveal transcriptomic differences between macrophages within RLTs (light zone \/dark zone, germinal center\/ interfollicular), and between disease states (RLTs\/ DLBCL), which we then use to generate six spatially-derived macrophage signatures (MacroSigs). We proceed to interrogate these MacroSigs in macrophage and DLBCL single-cell RNA-sequencing datasets, and in gene-expression data from multiple DLBCL cohorts. We show that specific MacroSigs are associated with cell-of-origin subtypes and overall survival in DLBCL. This study provides a spatially-resolved whole-transcriptome atlas of macrophages in reactive and malignant lymphoid tissues, showing biological and clinical significance.<\/jats:p>","DOI":"10.1038\/s41467-024-46220-z","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T06:29:47Z","timestamp":1709879387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Min","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Bertolazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Xue","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Jaynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1568-6581","authenticated-orcid":false,"given":"Kevin","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6343-176X","authenticated-orcid":false,"given":"Nicholas","family":"Syn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0364-6080","authenticated-orcid":false,"given":"Michal Marek","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1753-8547","authenticated-orcid":false,"given":"Yanfen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Thng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiya","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jayalakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogeshini","family":"Batumalai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8881-3537","authenticated-orcid":false,"given":"Sanjay","family":"De Mel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Hian Li","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Swee-Shan","family":"Hue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Tsung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Sung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. George","family":"Chandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7678-1152","authenticated-orcid":false,"given":"Xiaofei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1990-8804","authenticated-orcid":false,"given":"Qiang","family":"Pan-Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2857-7755","authenticated-orcid":false,"given":"Florent","family":"Ginhoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen Lin","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-6410","authenticated-orcid":false,"given":"Siok-Bian","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0821-6231","authenticated-orcid":false,"given":"Claudio","family":"Tripodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9816-6137","authenticated-orcid":false,"given":"Anand D.","family":"Jeyasekharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"key":"46220_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L. et al. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7\u201333 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"46220_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.critrevonc.2012.12.009","volume":"87","author":"M Martelli","year":"2013","unstructured":"Martelli, M. et al. Diffuse large B-cell lymphoma. Crit. Rev. Oncol. Hematol. 87, 146\u2013171 (2013).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"46220_CR3","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","volume":"116","author":"B Coiffier","year":"2010","unstructured":"Coiffier, B. et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte. Blood 116, 2040\u20132045 (2010).","journal-title":"Blood"},{"key":"46220_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrc3774","volume":"14","author":"DW Scott","year":"2014","unstructured":"Scott, D. W. & Gascoyne, R. D. The tumour microenvironment in B cell lymphomas. Nat. Rev. Cancer 14, 517\u2013534 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"46220_CR5","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1158\/2159-8290.CD-20-0839","volume":"11","author":"N Kotlov","year":"2021","unstructured":"Kotlov, N. et al. Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures. Cancer Discov. 11, 1468\u20131489 (2021).","journal-title":"Cancer Discov."},{"key":"46220_CR6","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/annonc\/mdy450","volume":"29","author":"S Ciavarella","year":"2018","unstructured":"Ciavarella, S. et al. Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue. Ann. Oncol. 29, 2363\u20132370 (2018).","journal-title":"Ann. Oncol."},{"key":"46220_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1158\/1078-0432.CCR-21-3140","volume":"28","author":"M Autio","year":"2022","unstructured":"Autio, M. et al. Clinical impact of immune cells and their spatial interactions in diffuse large B-Cell lymphoma microenvironment. Clin. Cancer Res. 28, 781\u2013792 (2022).","journal-title":"Clin. Cancer Res."},{"key":"46220_CR8","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3324\/haematol.2019.243626","volume":"106","author":"M Autio","year":"2021","unstructured":"Autio, M. et al. Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma. Haematologica 106, 718\u2013729 (2021).","journal-title":"Haematologica"},{"key":"46220_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6208-x","volume":"19","author":"YL Li","year":"2019","unstructured":"Li, Y. L. et al. Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count. BMC Cancer 19, 1049 (2019).","journal-title":"BMC Cancer"},{"key":"46220_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3324\/haematol.2014.113472","volume":"100","author":"S Riihijarvi","year":"2015","unstructured":"Riihijarvi, S. et al. Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial. Haematologica 100, 238\u2013245 (2015).","journal-title":"Haematologica"},{"key":"46220_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-022-01328-x","volume":"15","author":"W Li","year":"2022","unstructured":"Li, W. et al. Targeting macrophages in hematological malignancies: recent advances and future directions. J. Hematol. Oncol. 15, 110 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"46220_CR12","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.annonc.2021.08.1991","volume":"32","author":"GA Croci","year":"2021","unstructured":"Croci, G. A. et al. SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-\/triple-hit status. Ann. Oncol. 32, 1400\u20131409 (2021).","journal-title":"Ann. Oncol."},{"key":"46220_CR13","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1182\/blood.V126.23.5023.5023","volume":"126","author":"H Zeng","year":"2015","unstructured":"Zeng, H. et al. CD163+ tumor associated macrophages predict inferior outcome in patients with diffuse Large B-cell lymphoma treated with R-CHOP. Blood 126, 5023 (2015).","journal-title":"Blood"},{"key":"46220_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3324\/haematol.2015.124008","volume":"100","author":"R Kridel","year":"2015","unstructured":"Kridel, R., Steidl, C. & Gascoyne, R. D. Tumor-associated macrophages in diffuse large B-cell lymphoma. Haematologica 100, 143\u2013145 (2015).","journal-title":"Haematologica"},{"key":"46220_CR15","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3389\/fimmu.2020.01731","volume":"11","author":"K Wu","year":"2020","unstructured":"Wu, K. et al. Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment. Front. Immunol. 11, 1731 (2020).","journal-title":"Front. Immunol."},{"key":"46220_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","volume":"79","author":"PJ Murray","year":"2017","unstructured":"Murray, P. J. Macrophage polarization. Annu. Rev. Physiol. 79, 541\u2013566 (2017).","journal-title":"Annu. Rev. Physiol."},{"key":"46220_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ni.3324","volume":"17","author":"F Ginhoux","year":"2016","unstructured":"Ginhoux, F. et al. New insights into the multidimensional concept of macrophage ontogeny, activation and function. Nat. Immunol. 17, 34\u201340 (2016).","journal-title":"Nat. Immunol."},{"key":"46220_CR18","first-page":"263","volume":"6","author":"L Chavez-Galan","year":"2015","unstructured":"Chavez-Galan, L. et al. Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages. Front. Immunol. 6, 263 (2015).","journal-title":"Front. Immunol."},{"key":"46220_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani, A. et al. Macrophages as tools and targets in cancer therapy. Nat. Rev. Drug Discov. 21, 799\u2013820 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"46220_CR20","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1158\/0008-5472.CAN-18-1367","volume":"78","author":"M Yang","year":"2018","unstructured":"Yang, M. et al. Diverse functions of macrophages in different tumor microenvironments. Cancer Res. 78, 5492\u20135503 (2018).","journal-title":"Cancer Res."},{"key":"46220_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369\u2013382 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"46220_CR22","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/ijlh.12203","volume":"36","author":"KA Khalifa","year":"2014","unstructured":"Khalifa, K. A. et al. CD14(+) HLA-DR low\/(-) monocytes as indicator of disease aggressiveness in B-cell non-Hodgkin lymphoma. Int. J. Lab. Hematol. 36, 650\u2013655 (2014).","journal-title":"Int. J. Lab. Hematol."},{"key":"46220_CR23","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/eji.202149746","volume":"52","author":"V L\u2019Imperio","year":"2022","unstructured":"L\u2019Imperio, V. et al. Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88\/CD79B mutants-enriched diffuse large B-cell lymphomas. Eur. J. Immunol. 52, 1350\u20131361 (2022).","journal-title":"Eur. J. Immunol."},{"key":"46220_CR24","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1074\/jbc.M110.182733","volume":"286","author":"P Trikha","year":"2011","unstructured":"Trikha, P. et al. E2f1-3 are critical for myeloid development. J. Biol. Chem. 286, 4783\u20134795 (2011).","journal-title":"J. Biol. Chem."},{"key":"46220_CR25","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.3389\/fimmu.2017.01908","volume":"8","author":"C Xia","year":"2017","unstructured":"Xia, C. et al. S100 proteins as an important regulator of macrophage inflammation. Front. Immunol. 8, 1908 (2017).","journal-title":"Front. Immunol."},{"key":"46220_CR26","doi-asserted-by":"publisher","first-page":"e582","DOI":"10.1097\/HS9.0000000000000582","volume":"5","author":"K Basso","year":"2021","unstructured":"Basso, K. Biology of germinal center B cells relating to lymphomagenesis. Hemasphere 5, e582 (2021).","journal-title":"Hemasphere"},{"key":"46220_CR27","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1182\/blood-2012-03-415380","volume":"120","author":"GD Victora","year":"2012","unstructured":"Victora, G. D. et al. Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood 120, 2240\u20132248 (2012).","journal-title":"Blood"},{"key":"46220_CR28","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1002\/eji.202149235","volume":"51","author":"N Attaf","year":"2021","unstructured":"Attaf, N. et al. Heterogeneity of germinal center B cells: new insights from single-cell studies. Eur. J. Immunol. 51, 2555\u20132567 (2021).","journal-title":"Eur. J. Immunol."},{"key":"46220_CR29","doi-asserted-by":"publisher","first-page":"e20200483","DOI":"10.1084\/jem.20200483","volume":"217","author":"AB Holmes","year":"2020","unstructured":"Holmes, A. B. et al. Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome. J. Exp. Med. 217, e20200483 (2020).","journal-title":"J. Exp. Med."},{"key":"46220_CR30","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1073\/pnas.0500369102","volume":"102","author":"MJ Peart","year":"2005","unstructured":"Peart, M. J. et al. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc. Natl. Acad. Sci. USA 102, 3697\u20133702 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"46220_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.stem.2008.05.018","volume":"3","author":"A Raouf","year":"2008","unstructured":"Raouf, A. et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 3, 109\u2013118 (2008).","journal-title":"Cell Stem Cell"},{"key":"46220_CR32","first-page":"1892","volume":"32","author":"SM Zimmerman","year":"2022","unstructured":"Zimmerman, S. M. et al. Spatially resolved whole transcriptome profiling in human and mouse tissue using digital spatial profiling. Genome Res. 32, 1892\u20131905 (2022).","journal-title":"Genome Res."},{"key":"46220_CR33","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","volume":"54","author":"K Mulder","year":"2021","unstructured":"Mulder, K. et al. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity 54, 1883\u20131900.e1885 (2021).","journal-title":"Immunity"},{"key":"46220_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1021\/acsmedchemlett.2c00525","volume":"14","author":"AF Abdel-Magid","year":"2023","unstructured":"Abdel-Magid, A. F. Inhibitors of Interleukin 4 Induced Protein 1 (IL4I1) as potential treatment for cancer. ACS Med. Chem. Lett. 14, 127\u2013128 (2023).","journal-title":"ACS Med. Chem. Lett."},{"key":"46220_CR35","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","volume":"182","author":"A Sadik","year":"2020","unstructured":"Sadik, A. et al. IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression. Cell 182, 1252\u20131270.e1234 (2020).","journal-title":"Cell"},{"key":"46220_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01407-1","volume":"23","author":"L Zhu","year":"2023","unstructured":"Zhu, L., Wang, J. & Hu, J. High expression of IL4I1 is correlated with poor prognosis and immune infiltration in thyroid cancer. BMC Endocr. Disord. 23, 148 (2023).","journal-title":"BMC Endocr. Disord."},{"key":"46220_CR37","doi-asserted-by":"publisher","first-page":"110713","DOI":"10.1016\/j.celrep.2022.110713","volume":"39","author":"X Ye","year":"2022","unstructured":"Ye, X. et al. A single-cell atlas of diffuse large B cell lymphoma. Cell Rep. 39, 110713 (2022).","journal-title":"Cell Rep."},{"key":"46220_CR38","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz, R. et al. Genetics and pathogenesis of diffuse large B-Cell lymphoma. N. Engl. J. Med. 378, 1396\u20131407 (2018).","journal-title":"N. Engl. J. Med."},{"key":"46220_CR39","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood.2019003535","volume":"135","author":"SE Lacy","year":"2020","unstructured":"Lacy, S. E. et al. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological malignancy research network report. Blood 135, 1759\u20131771 (2020).","journal-title":"Blood"},{"key":"46220_CR40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy, B. et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat. Med. 24, 679\u2013690 (2018).","journal-title":"Nat. Med."},{"key":"46220_CR41","first-page":"2493","volume":"141","author":"W Alduaij","year":"2023","unstructured":"Alduaij, W. et al. Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population. Blood 141, 2493\u20132507 (2023).","journal-title":"Blood"},{"key":"46220_CR42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.trecan.2022.02.006","volume":"8","author":"M Revel","year":"2022","unstructured":"Revel, M. et al. C1q+ macrophages: passengers or drivers of cancer progression. Trends Cancer 8, 517\u2013526 (2022).","journal-title":"Trends Cancer"},{"key":"46220_CR43","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jtho.2022.04.009","volume":"17","author":"M Moutafi","year":"2022","unstructured":"Moutafi, M. et al. Discovery of biomarkers of resistance to immune checkpoint blockade in NSCLC using high-plex digital spatial profiling. J. Thorac. Oncol. 17, 991\u20131001 (2022).","journal-title":"J. Thorac. Oncol."},{"key":"46220_CR44","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1161\/CIRCRESAHA.121.320449","volume":"131","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Transcriptional and immune landscape of cardiac sarcoidosis. Circ. Res. 131, 654\u2013669 (2022).","journal-title":"Circ. Res."},{"key":"46220_CR45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41574-022-00675-6","volume":"18","author":"E Barreby","year":"2022","unstructured":"Barreby, E., Chen, P. & Aouadi, M. Macrophage functional diversity in NAFLD - more than inflammation. Nat. Rev. Endocrinol. 18, 461\u2013472 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"46220_CR46","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"G Lenz","year":"2008","unstructured":"Lenz, G. et al. Stromal gene signatures in large-B-cell lymphomas. N. Engl. J. Med. 359, 2313\u20132323 (2008).","journal-title":"N. Engl. J. Med."},{"key":"46220_CR47","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503\u2013511 (2000).","journal-title":"Nature"},{"key":"46220_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103055","volume":"61","author":"S Sangaletti","year":"2020","unstructured":"Sangaletti, S. et al. Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces. EBioMedicine 61, 103055 (2020).","journal-title":"EBioMedicine"},{"key":"46220_CR49","doi-asserted-by":"publisher","first-page":"1207959","DOI":"10.3389\/fimmu.2023.1207959","volume":"14","author":"C Tripodo","year":"2023","unstructured":"Tripodo, C. et al. Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLBCL at the periphery of the follicle. Front. Immunol. 14, 1207959 (2023).","journal-title":"Front. Immunol."},{"key":"46220_CR50","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.18.01314","volume":"37","author":"C Sha","year":"2019","unstructured":"Sha, C. et al. Molecular high-grade B-Cell lymphoma: defining a poor-risk group that requires different approaches to therapy. J. Clin. Oncol. 37, 202\u2013212 (2019).","journal-title":"J. Clin. Oncol."},{"key":"46220_CR51","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1200\/JCO.18.01583","volume":"37","author":"D Ennishi","year":"2019","unstructured":"Ennishi, D. et al. Double-Hit gene expression signature defines a distinct subgroup of germinal center B-Cell-Like diffuse large B-Cell Lymphoma. J. Clin. Oncol. 37, 190\u2013201 (2019).","journal-title":"J. Clin. Oncol."},{"key":"46220_CR52","doi-asserted-by":"crossref","unstructured":"Alduaij, W., et al. Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population. Blood 20, 2493\u20132507 (2022).","DOI":"10.1182\/blood.2022018248"},{"key":"46220_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101562","volume":"23","author":"C Tripodo","year":"2020","unstructured":"Tripodo, C. et al. A spatially resolved dark- versus light-zone microenvironment signature subdivides germinal center-related aggressive B Cell lymphomas. iScience 23, 101562 (2020).","journal-title":"iScience"},{"key":"46220_CR54","doi-asserted-by":"publisher","first-page":"e20210420","DOI":"10.1084\/jem.20210420","volume":"219","author":"A Patsalos","year":"2022","unstructured":"Patsalos, A. et al. A growth factor-expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15. J. Exp. Med. 219, e20210420 (2022).","journal-title":"J. Exp. Med."},{"key":"46220_CR55","doi-asserted-by":"publisher","first-page":"e20222173","DOI":"10.1084\/jem.20222173","volume":"220","author":"N Gurwicz","year":"2023","unstructured":"Gurwicz, N. et al. Tingible body macrophages arise from lymph node-resident precursors and uptake B cells by dendrites. J. Exp. Med. 220, e20222173 (2023).","journal-title":"J. Exp. Med."},{"key":"46220_CR56","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"46220_CR57","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"46220_CR58","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"46220_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2024.01.006","volume":"57","author":"R Massoni-Badosa","year":"2024","unstructured":"Massoni-Badosa, R. et al. An Atlas of cells in the human tonsil. Immunity 57, 1\u201321 (2024).","journal-title":"Immunity"},{"key":"46220_CR60","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1158\/1078-0432.CCR-16-1922","volume":"23","author":"S Dubois","year":"2017","unstructured":"Dubois, S. et al. Biological and clinical relevance of associated genomic alterations in MYD88 L265P and non-L265P-mutated diffuse large B-Cell lymphoma: analysis of 361 Cases. Clin. Cancer Res. 23, 2232\u20132244 (2017).","journal-title":"Clin. Cancer Res."},{"key":"46220_CR61","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","volume":"171","author":"A Reddy","year":"2017","unstructured":"Reddy, A. et al. Genetic and functional drivers of diffuse large B Cell Lymphoma. Cell 171, 481\u2013494.e415 (2017).","journal-title":"Cell"},{"key":"46220_CR62","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/leu.2012.83","volume":"26","author":"C Visco","year":"2012","unstructured":"Visco, C. et al. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 26, 2103\u20132113 (2012).","journal-title":"Leukemia"},{"key":"46220_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2019.04.004","volume":"235-236","author":"P Raman","year":"2019","unstructured":"Raman, P. et al. A comparison of survival analysis methods for cancer gene expression RNA-Sequencing data. Cancer Genet 235-236, 1\u201312 (2019).","journal-title":"Cancer Genet"},{"key":"46220_CR64","doi-asserted-by":"publisher","unstructured":"Sridhar, S. Spatially-resolved transcriptomics reveal macrophage heterogeneity. and prognostic significance in diffuse large B-cell lymphoma. Zenodo. https:\/\/doi.org\/10.5281\/zenodo.10511030 (2024).","DOI":"10.5281\/zenodo.10511030"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46220-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46220-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46220-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T06:30:12Z","timestamp":1709879412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46220-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["46220"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-46220-z","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,8]]},"assertion":[{"value":"26 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.D.J. has received consultancy fees from DKSH\/Beigene, Roche, Gilead, Turbine Ltd, AstraZeneca, Antengene, Janssen, MSD and IQVIA; and research funding from Janssen and AstraZeneca. The other co-authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2113"}}